Results 11 to 20 of about 15,426 (247)

Use of monoclonal antibodies for allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis: literature review

Therapeutic Advances in Respiratory Disease, 2020
Allergic bronchopulmonary aspergillosis (ABPA) is a hypersensitivity reaction (HR) mediated by antigens to Aspergillus fumigatus. It is estimated that 2–15% of patients with cystic fibrosis (CF) and between 1% and 5% of asthmatics develop ABPA, affecting
Isabel Eraso, S. Sangiovanni, E. Morales, L. Fernández-Trujillo   +3 more
semanticscholar   +3 more sources

Allergic bronchopulmonary aspergillosis in Japan: A nationwide survey.

Allergology International, 2018
BACKGROUND Allergic bronchopulmonary aspergillosis (ABPA) is an allergic pulmonary disease characterized by a hypersensitivity reaction to Aspergillus species colonizing the airways.
T. Oguma, M. Taniguchi, T. Shimoda, K. Kamei, H. Matsuse, A. Hebisawa, N. Takayanagi, S. Konno, K. Fukunaga, Kazuki Harada, Jun Tanaka, K. Tomomatsu, K. Asano   +12 more
semanticscholar   +3 more sources

Allergic bronchopulmonary aspergillosis: A multidisciplinary review.

Journal de Mycologie Médicale, 2023
Allergic bronchopulmonary aspergillosis (ABPA) is a rare disease characterized by a complex allergic inflammatory reaction of airways against Aspergillus affecting patients with chronic respiratory diseases (asthma, cystic fibrosis).
Amytis Roboubi, Camille Audousset, E. Fréalle, A. Brun, F. Laurent, J. Vitte, G. Mortuaire, G. Lefèvre, J. Cadranel, C. Chenivesse   +9 more
semanticscholar   +1 more source

Allergic bronchopulmonary aspergillosis with atopic, nonatopic, and sans asthma-Factor analysis.

Allergy. European Journal of Allergy and Clinical Immunology, 2023
BACKGROUND Allergic bronchopulmonary aspergillosis (ABPA) develops in the presence or absence of asthma, either atopic or nonatopic. We have tried to explore the essential components in the pathogenesis of the disease, which are either consistent and ...
N. Okada, Yoshiro Yamamoto, T. Oguma, Jun Tanaka, K. Tomomatsu, Y. Shiraishi, H. Matsuse, T. Shimoda, H. Kimura, K. Watai, Toshiyuki Harada, Y. Fujita, Y. Obase, M. Suzukawa, J. Suzuki, N. Takayanagi, T. Ishiguro, K. Masaki, K. Fukunaga, K. Asano   +19 more
semanticscholar   +1 more source

Omalizumab in allergic bronchopulmonary aspergillosis (ABPA): A systematic review and meta-analysis.

Journal of Allergy and Clinical Immunology: In Practice, 2022
BACKGROUND An unmet clinical need exists in the management of treatment-refractory allergic bronchopulmonary aspergillosis (ABPA). Omalizumab has shown promising effects in case series and cohort studies; however, evidence to support its routine clinical
Meiling Jin, J. Douglass, J. Elborn, R. Agarwal, W. Calhoun, S. Lazarewicz, X. Jaumont, Meng Yan   +7 more
semanticscholar   +1 more source

An Interesting Case of Allergic Bronchopulmonary Aspergillosis Resulting in Type II Respiratory Failure

Journal of Respiration, 2022
Aspergillus fumigatus can cause an immunological hypersensitivity reaction known as allergic bronchopulmonary aspergillosis (ABPA), which often worsens asthma and cystic fibrosis patients’ conditions.
Aman Nagar, Shubhajeet Roy, Jyoti Bajpai, Ajay Kumar Verma, Surya Kant   +4 more
doaj   +1 more source

Evaluation of Simpler Criteria for Diagnosing Allergic Bronchopulmonary Aspergillosis Complicating Asthma

Frontiers in Cellular and Infection Microbiology, 2022
Background The modified International Society for Human and Animal Mycology (ISHAM) allergic bronchopulmonary aspergillosis (ABPA) working group (AWG) criteria lists up to five components for diagnosing ABPA in asthmatics.
R. Agarwal, P. Saxena, V. Muthu, I. Sehgal, S. Dhooria, K. Prasad, A. Aggarwal, A. Chakrabarti   +7 more
semanticscholar   +1 more source

Clinical and immunological characteristics of Aspergillus fumigatus-sensitized asthma and allergic bronchopulmonary aspergillosis

Frontiers in Immunology, 2022
Background Aspergillus fumigatus (A.f) is a common airborne allergen that contributes to allergic asthma. In some patients, A.f can colonize in the airway and lead to allergic bronchopulmonary aspergillosis (ABPA).
Hao Chen, Xinyu Zhang, Li Zhu, Nairui An, Qing Jiang, Yaqi Yang, D. Ma, Lin Yang, R. Zhu   +8 more
semanticscholar   +1 more source

Critical asthma associated with allergic bronchopulmonary aspergillosis: Case report

Revista Peruana de Medicina Experimental y Salud Pública, 2020
Critical asthma syndrome is the most severe consequence of an acute asthma exacerbation. Allergic bronchopulmonary aspergillosis is one of the most frequent pathologies that mimic critical asthma syndrome and is associated with a high mortality risk when
Miguel A. Vences, Carol ManriqueVillegas, Julissa Mogollon-Lavi, Tatiana Arias-Rojas, Fernando Barriga Cari   +4 more
doaj   +1 more source

Biologic drugs in treating allergic bronchopulmonary aspergillosis in patients with cystic fibrosis: a systematic review

European Respiratory Review, 2022
Background Aspergillus fumigatus is a common saprophytic fungus causing allergic bronchopulmonary aspergillosis (ABPA) in patients with cystic fibrosis (CF).
S. Manti, Alessandro Giallongo, G. Parisi, M. Papale, E. Mulé, Donatella Aloisio, N. Rotolo, S. Leonardi   +7 more
semanticscholar   +1 more source